NEW YORK, Dec. 3, 2018 /PRNewswire/ -- Trusty.care, a New York-based healthcare tech startup, closed an $802k pre-seed financing round on Nov. 15, 2018. Trusty.care is the first senior-focused data-driven platform designed to reduce unnecessary health care costs using predictive analytics. Investors included StartUp Health, The Fund (Fund 1, a series of The Fund Series, LP), Eclectic Fund I (a series of Eclectic Fund Investments, LP), 37 Angels, Gaingels, and individual angel investors. Walter A. Winshall led the round, and Esther Dyson was first money in with an early investment in July 2018.
Trusty.care's platform mitigates the risk of incurring unnecessary healthcare costs for Medicare beneficiaries, helps them save on medications and care, and makes sure they are set up to maximize the benefits they are eligible for.
The first product in the market assists Medicare beneficiaries by identifying their projected out-of-pocket costs for the following year based on their current health care status and medications they are on, and to choose the best plan from a cost and coverage perspective.
"Our mission is that no senior should go through bankruptcy because of healthcare costs," says Trusty.care CEO Joseph Schneier.
The platform soft-launched on Oct. 15, 2018, providing data on 100 Medicare-covered medications, representing 80 percent of those most prescribed. By Dec. 1, 2018, Trusty.care had captured information on 13,000 medications, representing 100 percent of Medicare-covered medications. Trusty.care has been authorized by CMS (Centers for Medicare & Medicaid Services) for integration with beneficiary claims data (Blue Button 2.0), one of a limited number of companies in the country to have been so authorized.
Media contact: Julie Kennedy, email: firstname.lastname@example.org, phone: +1 202 256 4982